The two antivirals have been developed by MSD and Pfizer. MSD’s antiviral – Molnupiravir – has been shown to cut hospitalisation rates of Covid-19 patients by nearly half. It is also the first oral treatment that has been effective in treating Covid-19. The treatment works by targeting an enzyme the virus uses to make copies of itself. The Pfizer antiviral is in late-stage clinical development.
Alongside Allistair Booth (Picture), the Pinsent Masons team working on the deals included life sciences experts Mario Subramaniam, Niki Ruprai, Andrew Cornforth, Kiah York, Serena Hitchcock, Ioana Chiva and Jackie Harris.
Law Firms: Pinsent Masons;
Clients: UK Government;